share_log
Benzinga ·  Dec 17 06:01
Pfizer Reaffirms FY24 Outlook For Revenue Of $61B – $64B (Est $62.974B), Adj EPS Of $2.75 – $2.95 (Est $2.92)
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment